New drug combo tested in real world for Tough-to-Treat cancers
NCT ID NCT07387874
Summary
This study is observing how safe and effective a drug called Trastuzumab Rezetecan is for people with advanced solid tumors that have the HER2 protein and have come back or spread. The drug is being tested alone or in combination with other treatments in a real-world setting, not a tightly controlled trial. It involves about 30 adults whose cancer has progressed despite standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BeidahuangGGH
Harbin, China
Conditions
Explore the condition pages connected to this study.